Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) closed the day trading at $15.21 down -10.37% from the previous closing price of $16.97. In other words, the price has decreased by -$10.37 from its previous closing price. On the day, 2.1 million shares were traded.
Ratios:
For a better understanding of ARWR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.09 and its Current Ratio is at 6.09. In the meantime, Its Debt-to-Equity ratio is 16.58 whereas as Long-Term Debt/Eq ratio is at 16.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on June 05, 2024, initiated with a Neutral rating and assigned the stock a target price of $31.
On December 04, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $29.
On September 19, 2023, Citigroup started tracking the stock assigning a Neutral rating and target price of $33.Citigroup initiated its Neutral rating on September 19, 2023, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Anzalone Christopher Richard sold 166,667 shares for $18.03 per share. The transaction valued at 3,005,006 led to the insider holds 3,907,135 shares of the business.
Anzalone Christopher Richard sold 133,333 shares of ARWR for $2,269,328 on Mar 04 ’25. The Chief Executive Officer now owns 3,773,802 shares after completing the transaction at $17.02 per share. On Mar 04 ’25, another insider, Anzalone Christopher Richard, who serves as the Officer of the company, bought 133,333 shares for $17.02 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 767.18 while its Price-to-Book (P/B) ratio in mrq is 36.32.
Stock Price History:
Over the past 52 weeks, ARWR has reached a high of $35.47, while it has fallen to a 52-week low of $16.57. The 50-Day Moving Average of the stock is -21.16%, while the 200-Day Moving Average is calculated to be -31.21%.
Shares Statistics:
A total of 125.57M shares are outstanding, with a floating share count of 104.95M. Insiders hold about 16.77% of the company’s shares, while institutions hold 77.02% stake in the company.
